(±)-Epinephrine (hydrochloride) c acid lithium salt InChi: InChI=1S/C9H11N5O5/c10-13-12-6-4(3-15)19-8(7(6)17)14-2-1-5(16)11-9(14)18/h1-2

InChi: InChI=1S/C9H11N5O5/c10-13-12-6-4(3-15)19-8(7(6)17)14-2-1-5(16)11-9(14)18/h1-2

making hFAS an attractive metabolic target for the treatment of cancer

systemic dosing has yielded promising results in rats as well as humans

Smiles: C[C@@H]1O[C@@H](OC2C=C3OC(=C(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)C(=O)C3=C(O)C=2)C2C=CC(O)=CC=2)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O

CAY10650 is a potent cPLA2a inhibitor

(±)-Epinephrine (hydrochloride) c acid lithium salt InChi: InChI=1S/C9H11N5O5/c10-13-12-6-4(3-15)19-8(7(6)17)14-2-1-5(16)11-9(14)18/h1-2() Epinephrine is a natural neurotransmitter that is released from the adrenal medulla and activates adrenoceptors (Kis = 15, 735, and 3,970 nM for 1A , 2 , and 1 adrenergic receptors, respectively). Through these receptors, () epinephrine may induce either contraction or relaxation of vascular smooth muscle, depending on adrenoceptor subtype expression. Receptor mediated actions of () epinephrine are also relevant to blocking anaphylaxis, reversing